openPR Logo
Press release

Biopharmaceutical Contract Manufacturing Market – Global Industry Insights, Trends, Outlook, and Analysis, 2017 – 2025

04-25-2018 04:29 PM CET | Health & Medicine

Press release from: Medical Devices Report

Biopharmaceutical Contract Manufacturing Market – Global

Contract manufacturing organizations (CMOs) provide wide range of manufacturing services, which include contract packaging, quality testing, and development service to pharmaceutical and biotechnology industries. Biopharmaceutical companies prefer CMOs due to complexity in manufacturing process of biomolecules, as they consists of different shape, size, and behavior with significantly complex process than pharmaceutical drugs. Contract manufacturing organizations provide services from development of biologics to commercial scale production. Few companies also provide cell line development, fermentation, process optimization, and analytical characterization. Improved efficiency, weak product pipeline, and increasing price pressure is expected to favor the growth of biopharmaceutical contract manufacturing market in near future.

Request to download and view Sample Report: https://www.coherentmarketinsights.com/insight/request-sample/1077

Global Biopharmaceutical Contract Manufacturing Market Taxonomy:

On the basis of contract type, product type, and therapeutic application, global biopharmaceutical contract manufacturing market is segmented into:

By Contract Type:

Active Pharmaceutical Ingredient (API),Fill-And-Finished,.

By Product Type:

Interferons,Monoclonal Antibodies,Recombinant Hormone,Proteins,Vaccines,Vitamins,Insulin.

By Therapeutic Applications:

Oncology,Autoimmune Diseases,Metabolic Diseases,Cardiovascular Diseases,Neurology,Infectious Diseases,Others,.

Increasing outsourcing services in biopharmaceutical industry is expected to fuel the growth of biopharmaceutical contract manufacturing market

Pelican Therapeutics and subsidiary of Heat Biologics entered into a manufacturing agreement with KBI Biopharma in September, 2017. As per the agreement, KBI biopharma will provide development and manufacturing service under biopharmaceutical contract development and manufacturing organization (CDMO) for cGMP production of an antibody (PTX-35) and a fusion protein (PTX-15). Pelican Therapeutics intends to develop immunotherapy drugs by mimicking the production of antigen-specific T-cells. In May 2016, pelican received grant around US$ 15.2 million by Cancer Prevention and Research Institute of Texas (CPRIT) to its manufacturing efforts in immunotherapies for lung, pancreatic, lymphoma, prostate, and ovarian cancers.

Request a Customization: https://www.coherentmarketinsights.com/insight/request-customization/1077

Ajinomoto Althea, Inc., announced a GMP production suite in newly established High Potency Products (HPP) manufacturing site located in San Diego, California, in September 2017. Currently, Althea is offering process development and analytical services to the clients and from November 2017, the company will provide facilities for GMP manufacturing of bioconjugation and complex formulation. Apart from this services, Althea is aiming to provide full manufacturing services including fill-and-finish, which will start off in 2018.

Archaogen, Inc., received contract value from Biomedical Advanced Research and Development Authority (BARDA) around US$ 18 million in the support of product development, named C-Scape in September 2017. It is an orally administered antibacterial candidate developed to treat bacterial infections caused by the family of Enterobacteriaceae producing Extended Spectrum Beta-Lactamase (ESBL).

According to the annual report of BioPlan Associates, 2017, ongoing trends influencing the biopharmaceutical manufacturing growth are increasing international manufacturing centers, which include China and expansion of biosimilars and cell-and-gene therapy approvals.

Reducing cost and focusing on core strengths is expected to fuel the growth of biopharmaceutical contract manufacturing market

According to the Journal of Pharmaceutical Manufacturing in 2017, major factors driving the growth of biopharmaceutical contract manufacturing market include minimizing risk by outsourcing with other biopharma to achieve efficient product in minimum time interval, switching over the large biopharma companies to strengthen the weak pipeline product, and to cut off the costs of product development without risking financial investments. Moreover, CMOs offer services to companies lacking the capability to develop formula or product.

The key players in biopharmaceutical contract manufacturing market include Lonza Group Ltd., ProBioGen AG, Boehringher Ingelheim, BIOMEVA GmbH, Celonic GmbH, Sandoz, Fujifilm Diosynth Biotechnology, and Rentschler Biotechnologie.

To know more about the Biopharmaceutical Contract Manufacturing Market, click the link below: https://www.coherentmarketinsights.com/ongoing-insight/biopharmaceutical-contract-manufacturing-market-1077

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

1001 4th Ave,
#3200
Seattle, WA 98154

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Biopharmaceutical Contract Manufacturing Market – Global Industry Insights, Trends, Outlook, and Analysis, 2017 – 2025 here

News-ID: 1030648 • Views:

More Releases from Medical Devices Report

Bioabsorbable Stents Market - Global Industry Insights, Trends, Outlook, and Analysis, 2017-2025
Bioabsorbable Stents Market - Global Industry Insights, Trends, Outlook, and Ana …
The increase in prevalence of cardiovascular diseases globally is the major driving factor for the growth of bioabsorbable stents market. Additionally, increase in risk of late stent thrombosis, and restenosis due to use of conventional drug eluting stents is stimulating the use of new advanced biodegradable stents which degrades after a period. According to American Heart Association (AHS) in 2008, the mortality rate due to late stents thrombosis was around
Audiology Devices Market - Global Industry Insights, Trends, Size, Share, Outlook, and Analysis, 2017–2025
Audiology Devices Market - Global Industry Insights, Trends, Size, Share, Outloo …
Deafness is encountered mainly as a result of an impairment in the ear or damage to the nerves associated with hearing. The causes for these defects may range as congenital defect, injury, disease, side effects of medications, age-related factors, exposure to loud noise, and others. Audiology devices refers to assistive tools that helps a person to enhance its hearing ability under certain medical conditions that results into inability to hear.
Anti-Snoring Treatment Market - Global Industry Insights, Trends, Outlook, And Analysis, 2017-2025
Anti-Snoring Treatment Market - Global Industry Insights, Trends, Outlook, And A …
Snoring is the vibration of respiratory structures which results in sound while sleeping. It is a sleeping disorder caused due to monotonous narrowing and collapsing of the upper airway. Snoring have various adverse effects on health include coronary artery disease, systemic hypertension, atrial fibrillation, and stroke. Snoring is one of the factors of sleep deprivation, which may be further caused due to throat weakness, mis-positioned jaw, obesity, and obstruction in
Transplant Diagnostics Market is Projected to Reach Valuation Of US$ 1,127.6 Million By 2025
Transplant Diagnostics Market is Projected to Reach Valuation Of US$ 1,127.6 Mil …
The Global Transplant Diagnostics Market, By Product Type (Instrument, Reagents & Kits, and Software), By Technology (Molecular Assay (PCR-Based and Sequencing – Based), and Non-Molecular Assay), By Application (Tissue Typing, Infectious Disease Testing, Serum-Cross Matching, and Blood Profiling), By Organ Type (Kidney, Liver, Heart, Lungs, Pancreas, and Others), By End User (Hospitals & Transplant Centers, Research Laboratories & Academic Institutes, and Commercial Service Providers), and By Region (North America, Latin

All 5 Releases


More Releases for Contract

Contract Lifecycle Management Software Market Overview: Streamlining Contract Pr …
In recent years, the global Contract Lifecycle Management Software Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on Contract Lifecycle Management Software Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot
Contract Lifecycle Management Software Market Overview: Streamlining Contract Pr …
In recent years, the global Contract Lifecycle Management Software Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on Contract Lifecycle Management Software Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot
Contract Farming Market Beyond the Contract: How Consumer Preferences are Reshap …
Contract Farming Market worth $76.07 Bn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd. InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Contract Farming Market- (By Crop Type (Cereals (e.g., wheat, rice, maize), Fruits, Vegetables, Oilseeds, Pulses, Others), By Livestock Type (Poultry, Dairy, Swine, Cattle, Aquaculture, Others, By Contracting Parties (Agribusiness firms, Processors, Cooperatives, Exporters, Retailers, Others)), Trends, Industry Competition Analysis,
Pharmaceutical Contract Manufacturing and Contract Market 2021 | Detailed Report
The Pharmaceutical Contract Manufacturing and Contract research report combines vital data incorporating the competitive landscape, global, regional, and country-specific market size, market growth analysis, market share, recent developments, and market growth in segmentation. Furthermore, the Pharmaceutical Contract Manufacturing and Contract research report offers information and thoughtful facts like share, revenue, historical data, and global market share. It also highlights vital aspects like opportunities, driving, product scope, market overview, and driving
Contract Staffing Company India | Contract Staffing Services Mumbai & Banglore - …
Characterised with stringent legislation, fluctuating demand, a paucity of employable talent and market unpredictability, the modern business landscape offers a convincing rationale to employ a contract workforce in the business. You may not want to compromise on profits when you can adopt a 'just-in-time' strategy to bring the best workforce on-board using a contract staffing approach. With our cutting-edge contract staffing services, you can have all in one shot: An
Pharmaceutical Contract Manufacturing and Contract Market Size, Share, Developme …
LP INFORMATION offers a latest published report on Pharmaceutical Contract Manufacturing and Contract Market Analysis and Forecast 2020-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. According to this study, over the next five years the Pharmaceutical Contract Manufacturing and Contract market will register a 6.6% CAGR in terms of revenue, the global market size will reach $ 97680 million by 2025, from $